Who makes Daclatasvir Zeta?

Daclatasvir Zeta is developed by Genuine Research Center, Egypt.

What development phase is Daclatasvir Zeta in?

Daclatasvir Zeta is in Phase 1.

Last reviewed 2026-04-20 · How we verify

Daclatasvir Zeta

Genuine Research Center, Egypt · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Daclatasvir Zeta
Also known as	Daklinza
Sponsor	Genuine Research Center, Egypt
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Bioequivalence Study of Daclatasvir From Daclatasvir Zeta 60 mg Film Coated Tablets (Zeta Pharm Pharmaceutical Industries, Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK) (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Daclatasvir Zeta CI brief — competitive landscape report
Daclatasvir Zeta updates RSS · CI watch RSS
Genuine Research Center, Egypt portfolio CI